-
1
GRHL2-HER3 and E-cadherin mediate EGFR-bypass drug resistance in lung cancer cells
Published 2025-01-01Subjects: Get full text
Article -
2
-
3
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
Published 2019-03-01Subjects: “…human epidermal growth factor receptor 3 (HER3)…”
Get full text
Article